Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis

Table 1

Relationship between WDFY3-AS2 expression and clinical characteristics of EC patients.

Item	Cases (n = 36)	WDFY3-AS2		value
		Low (n = 17)	High (n = 19)
Age (years)				0.709
<60	16	7	9
≥60	20	10	10
Gender				0.194
Female	21	8	13
Male	15	9	6
Tumor location				0.342
Upper/middle	22	9	13
Lower	14	8	6
Tumor size				0.985
<4 cm	17	8	9
≥4 cm	19	9	10
Tumor grading				0.018
G1	12	9	3
G2/3	24	8	16
TNM stage				0.007
I-II	13	10	3
III-IV	23	7	16